Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Fluorouracil,Calcium Folinate,Oxaliplatin
Therapeutic Area : Oncology
Study Phase : Preclinical
Sponsor : Allarity Therapeutics
Deal Size : Undisclosed
Deal Type : Collaboration
Details : Under the Agreement, Allarity will support FivepHusion’s future clinical development of Deflexifol (5-fluorouracil) for the treatment of solid tumors by using certain of Allarity’s drug-specific DRP® companion diagnostics, including its validated DR...
Brand Name : Deflexifol
Molecule Type : Small molecule
Upfront Cash : Undisclosed
July 31, 2023
Lead Product(s) : Fluorouracil,Calcium Folinate,Oxaliplatin
Therapeutic Area : Oncology
Highest Development Status : Preclinical
Sponsor : Allarity Therapeutics
Deal Size : Undisclosed
Deal Type : Collaboration
Lead Product(s) : Fluorouracil,Calcium Folinate
Therapeutic Area : Oncology
Study Phase : Phase I/ Phase II
Sponsor : Syneos Health
Deal Size : Undisclosed
Deal Type : Collaboration
FivepHusion Announces Strategic Collaboration with Treehill Partners and Syneos Health
Details : The collaboration is for strategically and optimally progress development and commercialization of FivepHusion's enhanced chemotherapeutic formulation Deflexifol, an anti-cancer drug reformulation combining 5-fluorouracil and its biomodulator leucovorin,...
Brand Name : Deflexifol
Molecule Type : Small molecule
Upfront Cash : Undisclosed
May 26, 2023
Lead Product(s) : Fluorouracil,Calcium Folinate
Therapeutic Area : Oncology
Highest Development Status : Phase I/ Phase II
Sponsor : Syneos Health
Deal Size : Undisclosed
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?